Cougar Biotech and the FDA Agree on new Abiraterone Trial

An announcement from Market Watch claims that Cougar Biotechnology has come to an agreement with the US Food & Drug Administration (FDA) to conduct an additional Phase III trial of abiraterone acetate in prostate cancer. The currently ongoing and much in demand Phase III trial of abiraterone acetate was designed for prostate cancer survivors who [...]

Scott Goodwin Completes His 5th Chemotherapy Session

How does the song go- "Suddenly, I'm not half the man I used to be.” That is a feeling that I have experienced and that I believe we all will experience. Nevertheless, we have to continue to plow through our treatments, pills, endless doctors appointments and, of course the co-pays. I do find that it [...]

A Clinical Trial : Ixabepilone, Mitoxantrone, and Prednisone in Treating Patients with Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy

I was recently reviewing current clinical trials and came across this one for men who have failed chemotherapy, what many of us view as the final treatment for advanced prostate cancer. It provides a potential opportunity to combine two different therapy agents (one old, mitoxantrone; one relatively new, ixabepilone). Both of these chemicals are known [...]

An NCI Clinical Trail After Chemotherapy Has Failed

What do advanced prostate cancer survivors do once we fail chemotherapy? At this time there are no FDA approved next steps other than to take some time off and pray that restarting chemotherapy will again help us. To put in another way, we wait to die. There is a huge need to find additional strategies [...]

Living Day to Day (Living by PSA)- An Installment of Scott Goodwin’s Personal Experience with Chemotherapy

I completed my third treatment on Christmas Eve. I felt pretty good through the holiday weekend but started to fade a little by Sunday. The major side effect at this point is fatigue. As most of you know taking a nap doesn't always help, but still feels good. Despite the treatment we are on, we [...]

Go to Top